High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea

被引:196
|
作者
Ko, Kwan Soo
Suh, Ji Yoeun
Kwon, Ki Tae
Jung, Sook-In
Park, Kyong-Hwa
Kang, Cheol In
Chung, Doo Ryeon
Peck, Kyong Ran
Song, Jae-Hoon
机构
[1] Sungkyunkwan Univ, Samsung Med Ctr, Div Infect Dis, Seoul 135710, South Korea
[2] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon, South Korea
[3] Asian Pacific Res Fdn Infect Dis ARFID, Seoul 135710, South Korea
[4] Daegu Fatima Hosp, Div Infect Dis, Taegu, South Korea
[5] Chonnam Natl Univ, Sch Med, Kwangju, South Korea
关键词
rpoB; antimicrobial resistance; subgrouping;
D O I
10.1093/jac/dkm305
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: To investigate antimicrobial resistance in clinical isolates of Acinetobacter spp. from two Korean hospitals. Methods: Two hundred and sixty-five isolates of Acinetobacter spp. from two Korean hospitals were collected and were identified to species level using partial rpoB gene sequences. Antimicrobial susceptibility testing was performed using a broth microdilution method. Results: rpoB gene sequences indicated that 214 isolates (80.8%) were Acinetobacter baumannii, and allowed these to be classified into three subgroups (I, II and III); 142 isolates (53.6%) belonged to subgroup I, 54 (20.4%) to subgroup II and 18 (6.8%) to subgroup III. Forty-eight isolates (18.1%) and 74 isolates (27.9%) were resistant to polymyxin B and colistin, respectively. However, antimicrobial resistance rates varied markedly between subgroups. While A. baumannii subgroup I showed low resistance rates to polymyxin B and colistin (2.1% and 7.0%, respectively), subgroups II and III showed high resistance rates to these antibiotics (38.9% and 64.8% in subgroup II and 72.2% and 88.9%, in subgroup III, respectively). Multidrug resistance was also significantly more frequent in subgroup I (45.1%) than in subgroups II and III (13.0% and 16.7%, respectively). Conclusions: Our data indicate that subgroup identification of A. baumannii may aid selection of appropriate antimicrobial agents for the treatment of Acinetobacter infections.
引用
收藏
页码:1163 / 1167
页数:5
相关论文
共 50 条
  • [31] Evaluation of resazurin-based rapid test to detect colistin resistance in Acinetobacter baumannii isolates
    Germ, Julija
    Poirel, Laurent
    Kisek, Tjasa Cerar
    Spik, Vesna Cvitkovic
    Seme, Katja
    Premru, Manica Mueller
    Zupanc, Tatjana Lejko
    Nordmann, Patrice
    Pirs, Mateja
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2019, 38 (11) : 2159 - 2162
  • [32] Phage-mediated colistin resistance in Acinetobacter baumannii
    Lucidi, Massimiliano
    Imperi, Francesco
    Artuso, Irene
    Capecchi, Giulia
    Spagnoli, Cinzia
    Visaggio, Daniela
    Rampioni, Giordano
    Leoni, Livia
    Visca, Paolo
    DRUG RESISTANCE UPDATES, 2024, 73
  • [33] New Mutations Involved in Colistin Resistance in Acinetobacter baumannii
    Sun, Bingbing
    Liu, Haiyan
    Jiang, Yu
    Shao, Lei
    Yang, Sheng
    Chen, Daijie
    MSPHERE, 2020, 5 (02)
  • [34] Colistin Resistance in Acinetobacter baumannii: Basic and Clinical Insights
    Kamoshida, Go
    Yamada, Noriteru
    Yamaguchi, Daiki
    Yahiro, Kinnosuke
    Morita, Yuji
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2025, 48 (03) : 213 - 221
  • [35] The cost of resistance to colistin in Acinetobacter baumannii: a proteomic perspective
    Fernandez-Reyes, Maria
    Rodriguez-Falcon, Manuel
    Chiva, Cristina
    Pachon, Jeronimo
    Andreu, David
    Rivas, Luis
    PROTEOMICS, 2009, 9 (06) : 1632 - 1645
  • [36] Colistin Resistance in Acinetobacter baumannii: Molecular Mechanisms and Epidemiology
    Novovic, Katarina
    Jovcic, Branko
    ANTIBIOTICS-BASEL, 2023, 12 (03):
  • [37] Colistin Resistance in Environmental Isolates ofAcinetobacter baumannii
    Jovcic, Branko
    Novovic, Katarina
    Dekic, Svjetlana
    Hrenovic, Jasna
    MICROBIAL DRUG RESISTANCE, 2021, 27 (03) : 328 - 336
  • [38] Treatment Strategies of Colistin Resistance Acinetobacter baumannii Infections
    Papazachariou, Andria
    Tziolos, Renatos-Nikolaos
    Karakonstantis, Stamatis
    Ioannou, Petros
    Samonis, George
    Kofteridis, Diamantis P.
    ANTIBIOTICS-BASEL, 2024, 13 (05):
  • [39] Prevalence of colistin resistance in clinical isolates of Acinetobacter baumannii: a systematic review and meta-analysis
    Bostanghadiri, Narjess
    Narimisa, Negar
    Mirshekar, Maryam
    Dadgar-Zankbar, Leila
    Taki, Elahe
    Navidifar, Tahereh
    Darban-Sarokhalil, Davood
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2024, 13 (01)
  • [40] Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates
    Trebosc, Vincent
    Gartenmann, Sarah
    Totzl, Marcus
    Lucchini, Valentina
    Schellhorn, Birgit
    Pieren, Michel
    Lociuro, Sergio
    Gitzinger, Marc
    Tigges, Marcel
    Bumann, Dirk
    Kemmer, Christian
    MBIO, 2019, 10 (04):